STOCK TITAN

[6-K] 111, Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Analyzing...
Positive
  • None.
Negative
  • None.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2025

 

Commission file number: 001-38639

 

111, Inc.

3-4/F, No.295 ZuChongZhi Road,

Pudong New Area

Shanghai, 201203

The People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.    Form 20-F    Form 40-F

 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
99.1   111, Inc. Announces Second Quarter 2025 Unaudited Financial Results

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    111, INC.
     
Date: September 17, 2025   By: /s/ Junling Liu
        Name: Junling Liu
        Title: Chief Executive Officer

 

111

NASDAQ:YI

YI Rankings

YI Latest News

YI Latest SEC Filings

YI Stock Data

41.86M
3.47M
15.84%
23.88%
0.01%
Medical Distribution
Healthcare
Link
China
Shanghai